TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Jacomm /Pharma AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
12,807
|
13,398
|
12,106 |
| Financial expenses |
81
|
41
|
41 |
| Earnings before taxes |
-220
|
884
|
369 |
| EBITDA |
-157
|
931
|
421 |
| Total assets |
5,389
|
5,324
|
4,643 |
| Current assets |
5,341
|
5,313
|
4,621 |
| Current liabilities |
3,432
|
2,099
|
2,091 |
| Equity capital |
1,010
|
2,190
|
1,491 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
3
|
3
|
3 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
18.7%
|
41.1%
|
32.1% |
| Turnover per employee |
4,269
|
4,466
|
4,035 |
| Profit as a percentage of turnover |
-1.7%
|
6.6%
|
3.0% |
| Return on assets (ROA) |
-2.6%
|
17.4%
|
8.8% |
| Current ratio |
155.6%
|
253.1%
|
221.0% |
| Return on equity (ROE) |
-21.8%
|
40.4%
|
24.7% |
| Change turnover |
-591
|
1,292
|
441 |
| Change turnover % |
-4%
|
11%
|
4% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.